Filing Details

Accession Number:
0001415889-23-006300
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-05 17:00:12
Reporting Period:
2023-04-03
Accepted Time:
2023-04-05 17:00:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551152 Abbvie Inc. ABBV Pharmaceutical Preparations (2834) 320375147
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1951400 C Perry Siatis 1 N. Waukegan Road
North Chicago IL 60064
Evp, Gc And Secretary No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2023-04-03 3,520 $105.92 13,897 No 4 M Direct
Common Stock, $0.01 Par Value Disposition 2023-04-03 3,520 $160.00 10,377 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to buy) Disposition 2023-04-03 3,520 $105.92 3,520 $105.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,520 2022-02-18 2031-02-17 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.